{"log_id": 3319376913697747179, "direction": 0, "words_result_num": 29, "words_result": [{"probability": {"variance": 0.029848, "average": 0.889679, "min": 0.41117}, "location": {"width": 1019, "top": 294, "height": 45, "left": 372}, "words": "C)在1-g的剂量范围网与用药剂量呈比例关系根据结合托特罗定的血清浓度"}, {"probability": {"variance": 0.013349, "average": 0.91465, "min": 0.512389}, "location": {"width": 1063, "top": 354, "height": 45, "left": 329}, "words": "其5羟甲基代谢产物血清浓度之和(“有活的部分”),特罗定释剂4ng,每日1次"}, {"probability": {"variance": 0.033509, "average": 0.87576, "min": 0.351635}, "location": {"width": 1060, "top": 413, "height": 45, "left": 329}, "words": "用药约AUC与托特罗定速片ng(2g,每口2次)的AT相尚托特罗定缓释剂的"}, {"probability": {"variance": 0.026841, "average": 0.909149, "min": 0.421336}, "location": {"width": 1005, "top": 473, "height": 45, "left": 386}, "words": "和Cin水平分别为千特罗定速释片的75%和150%托持罗定缓剂的最大血行浓变"}, {"probability": {"variance": 0.019518, "average": 0.926568, "min": 0.565928}, "location": {"width": 253, "top": 541, "height": 32, "left": 331}, "words": "见于用药后2-6小时。"}, {"probability": {"variance": 0.001888, "average": 0.972786, "min": 0.85825}, "location": {"width": 697, "top": 615, "height": 38, "left": 386}, "words": "食物的影响:食物对托特罗定缓释剂的药代动学没有影响"}, {"probability": {"variance": 0.016027, "average": 0.913803, "min": 0.5829}, "location": {"width": 1003, "top": 695, "height": 38, "left": 384}, "words": "分布r托特罗定与s血浆蛋白高度结合,主要是与红酸性糖蛋白结合,在临床究所达"}, {"probability": {"variance": 0.023545, "average": 0.90559, "min": 0.355959}, "location": {"width": 1049, "top": 749, "height": 45, "left": 331}, "words": "到的浓度范围内,求结合托罗定的浓度平均为3.710.13%。托罗定的5甲基代谢产"}, {"probability": {"variance": 0.019013, "average": 0.944244, "min": 0.399458}, "location": {"width": 1058, "top": 813, "height": 41, "left": 329}, "words": "物与清蛋白的结合不多,米结合部分的浓度平均为36%4.0%托特罗定及其5羟甲基代"}, {"probability": {"variance": 0.033917, "average": 0.893273, "min": 0.397982}, "location": {"width": 1047, "top": 871, "height": 43, "left": 329}, "words": "谢产物的血和血浓度之比分别为0.5和0.8,说明这些化比没有广泛分布到红细胞中"}, {"probability": {"variance": 0.039619, "average": 0.849255, "min": 0.437798}, "location": {"width": 743, "top": 935, "height": 36, "left": 331}, "words": "托罗定按1,28mg剂静内用药后,其分布容积为1326.7I"}, {"probability": {"variance": 0.022063, "average": 0.91328, "min": 0.490168}, "location": {"width": 978, "top": 1012, "height": 43, "left": 384}, "words": "代谢:托特罗定二给药后肝广泛代谢,主要代谢途径包括5-甲基基团的氧"}, {"probability": {"variance": 0.005368, "average": 0.94012, "min": 0.771067}, "location": {"width": 1063, "top": 1072, "height": 43, "left": 326}, "words": "这是由细素P4502D6(CYP2D6)介的,结果形成了有药理学活性的5-甲基代"}, {"probability": {"variance": 0.02224, "average": 0.924452, "min": 0.438681}, "location": {"width": 1060, "top": 1134, "height": 38, "left": 329}, "words": "谢产物。进一步代谢则形成5-酸和N-脱烷基S-酸代谢广物,这两种代产分别占尿"}, {"probability": {"variance": 0.018187, "average": 0.915435, "min": 0.498612}, "location": {"width": 567, "top": 1195, "height": 34, "left": 331}, "words": "中回收的代谢产物总量的51%±14%和29%+63%"}, {"probability": {"variance": 0.031816, "average": 0.846365, "min": 0.389976}, "location": {"width": 1003, "top": 1271, "height": 43, "left": 384}, "words": "代谢的变异:部分(约7)高加索白人缺乏<Y酶:这种海负责扎特罗定5-"}, {"probability": {"variance": 0.036282, "average": 0.873357, "min": 0.355791}, "location": {"width": 1065, "top": 1335, "height": 36, "left": 326}, "words": "羟甲基代谢产物的形成,发现在这些人“弱代谢”的代谢途径是通过细色素P4503A"}, {"probability": {"variance": 0.02443, "average": 0.885521, "min": 0.447365}, "location": {"width": 1060, "top": 1387, "height": 48, "left": 329}, "words": "海(CYP3A4)烷形成N-脱烷托特罗定。该人样中共他的人则被称为“强代训者”药"}, {"probability": {"variance": 0.006475, "average": 0.954698, "min": 0.589396}, "location": {"width": 1058, "top": 1449, "height": 43, "left": 329}, "words": "代动力学研充发现:弱代谢者中托寺罗定的代谢速度比在强代谢者中的代谢速度慢,这就导"}, {"probability": {"variance": 0.027938, "average": 0.870463, "min": 0.376087}, "location": {"width": 907, "top": 1511, "height": 38, "left": 331}, "words": "红托特罗定的血清浓度明显比较高,而其5-羟基代产物的浓度可忽略不计"}, {"probability": {"variance": 0.017648, "average": 0.926586, "min": 0.452663}, "location": {"width": 1003, "top": 1591, "height": 38, "left": 384}, "words": "排泄:继康志者口服5mgc-特罗定溶液后,7日内尿中回收了77%的放射性标志"}, {"probability": {"variance": 0.022759, "average": 0.911497, "min": 0.391811}, "location": {"width": 1058, "top": 1648, "height": 45, "left": 329}, "words": "物,粪住中回收了17%放射性标志物。所回收的完整托特罗定不到给约剂量的1%(在"}, {"probability": {"variance": 0.024521, "average": 0.900722, "min": 0.469529}, "location": {"width": 1056, "top": 1707, "height": 45, "left": 331}, "words": "代者中<25%),所回收的标志物中,5%-14%(弱代谢者中<1%〕是有活性的5轻甲"}, {"probability": {"variance": 0.033208, "average": 0.860327, "min": 0.536617}, "location": {"width": 132, "top": 1776, "height": 32, "left": 333}, "words": "基代谢产物"}, {"probability": {"variance": 0.019108, "average": 0.913646, "min": 0.533367}, "location": {"width": 1058, "top": 1847, "height": 45, "left": 329}, "words": "妻4中总结了强代谢者(EM)和弱代谢者(PM)中托特罗定缓释剂及式5-径平基代谢产物"}, {"probability": {"variance": 0.020297, "average": 0.92032, "min": 0.372471}, "location": {"width": 1021, "top": 1909, "height": 43, "left": 331}, "words": "药代动力学参数的平均值(土标准差)这些数据是在17名康另考(13名卫M"}, {"probability": {"variance": 0.029128, "average": 0.880392, "min": 0.431637}, "location": {"width": 848, "top": 1968, "height": 43, "left": 331}, "words": "名PM),用托特罗定缓释剂单剂量和每日1次多料量绘药后获得的"}, {"probability": {"variance": 0.031957, "average": 0.840099, "min": 0.544265}, "location": {"width": 192, "top": 2041, "height": 32, "left": 763}, "words": "第:1,共1"}, {"probability": {"variance": 0.022765, "average": 0.877149, "min": 0.480274}, "location": {"width": 157, "top": 2075, "height": 27, "left": 386}, "words": "nNo:20130502"}], "language": 3}